Researchers from Wageningen University & Research and Van Andel Institute used a variant of CRISPR, a gene-editing tool, to ...

The gene editing treatment targets the relatively common 1717-1G>A splicing mutation, which does not respond to many current CF therapies.

Cancer cells excel at evading detection, but subtle chemical differences set them apart from healthy cells. Now, a team of ...

For the millions of people living with genetic diseases like muscular dystrophy and inherited liver disorders, one of the ...

For the first time, a team of researchers from Stellenbosch University (SU) and the Agricultural Research Council has ...

Now, following up on that success, a large Chinese collaboration has followed up with a description of an improved gene ...

Rapid expansion in clinical applications, rising demand for genomic diagnostics, and increased investment in CRISPR-based therapeutics are fueling one of the fastest-growing life sciences ...

Head and neck cancers often begin in the mouth, throat, or voice box. They're among the most common cancers in the world, affecting over half a million people each year and causing about 300,000 ...

DENVER, Jan. 28, 2026 (GLOBE NEWSWIRE) -- CRISPR gene-editing, and related genome engineering technologies, are reshaping industries from medicine to materials, with breakthroughs in treating genetic ...

CRISPR technology, enabling precise DNA editing, drives gene-editing stocks with major disease treatment potential. Leading companies like Intellia Therapeutics, CRISPR Therapeutics, and Beam focus on ...